GETTING MY DIOSCIN TO WORK

Steer clear of coadministration of sensitive CYP3A4 substrates with ivosidenib or replace with alternate therapies. If coadministration is unavoidable, watch patients for loss of therapeutic outcome of these prescription drugs.indinavir will raise the level or outcome of pazopanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear